The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Limited stage nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): A subgroup analysis of the HD.6 clinical trial.
 
Bethany Monteith
No Relationships to Disclose
 
Erica C. DiMaria
No Relationships to Disclose
 
Michael Crump
No Relationships to Disclose
 
Jeffrey B. Ames
No Relationships to Disclose
 
Jane N. Winter
Consulting or Advisory Role - Ariad (I); Bristol-Myers Squibb (I); Celgene (I); CVS Caremark (I); Novartis (I); Pfizer (I)
Research Funding - Astellas Pharma (Inst); Celgene (I); Curis; Daiichi Sankyo (I); ERYTECH Pharma (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
 
Marina Djurfeldt
No Relationships to Disclose
 
Lois E. Shepherd
No Relationships to Disclose
 
Ralph M. Meyer
No Relationships to Disclose
 
Bingshu E. Chen
No Relationships to Disclose
 
Annette E. Hay
Research Funding - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Roche (Inst)